Regenxbio (RGNX) Treasury Shares (2014 - 2026)
Regenxbio (RGNX) posted quarterly Treasury Shares of $2.8 million for Q4 2025, up 39.57% year-over-year from $2.0 million in Q4 2024, and down 1.86% quarter-over-quarter from $2.9 million in Q3 2025.
Regenxbio (RGNX) Treasury Shares (2014 - 2026) Analysis & Trends
Regenxbio's Treasury Shares history runs 10 years deep, the most recent figure standing at $2.8 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 39.57% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 39.57% YoY), while the FY2025 annual figure was $2.8 million, up 39.57% from the prior year.
- Treasury Shares for Q4 2025 stood at $2.8 million, down from $2.9 million in the prior quarter.
- The five-year high for Treasury Shares was $3.0 million in Q2 2025, with the low at $254000.0 in Q1 2021.
- The 5-year median for Treasury Shares is $1.4 million (2023), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares surged 200.42% in 2023, then grew 17.13% in 2024.
- Regenxbio's Treasury Shares stood at $277000.0 in 2021, then surged by 121.3% to $613000.0 in 2022, then jumped by 113.54% to $1.3 million in 2023, then jumped by 56.0% to $2.0 million in 2024, then surged by 39.57% to $2.8 million in 2025.
- Business Quant data shows RGNX's Treasury Shares at $2.8 million in Q4 2025, $2.9 million in Q3 2025, and $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.85 Mn |
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Dec 31, 2023 | 1.31 Mn |